Clinical Trial Update: Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 1/2 study evaluating injections of allogeneic mesenchymal stem cells in adults with refractory systemic sclerosis; the trial h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• Allogeneic mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: SYSTEMIC SCLERODERMA, ALLOGENEIC MESENCHYMAL STEM CELLS | Phase 1, Phase 2 | Status: COMPLETED